[go: up one dir, main page]

TN2017000478A1 - Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity. - Google Patents

Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity.

Info

Publication number
TN2017000478A1
TN2017000478A1 TNP/2017/000478A TN2017000478A TN2017000478A1 TN 2017000478 A1 TN2017000478 A1 TN 2017000478A1 TN 2017000478 A TN2017000478 A TN 2017000478A TN 2017000478 A1 TN2017000478 A1 TN 2017000478A1
Authority
TN
Tunisia
Prior art keywords
dermatitises
mucosae
dermis
pathologies
compositions
Prior art date
Application number
TNP/2017/000478A
Inventor
Roberto Logi
Original Assignee
Roberto Logi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Logi filed Critical Roberto Logi
Publication of TN2017000478A1 publication Critical patent/TN2017000478A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity containing as active ingredients Croton lech/eri resin extract and Melaleuca alternifolia essential oil in combination with possible other excipients.
TNP/2017/000478A 2015-05-14 2016-05-13 Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity. TN2017000478A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB20150388 2015-05-14
PCT/IB2016/052770 WO2016181355A1 (en) 2015-05-14 2016-05-13 Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity

Publications (1)

Publication Number Publication Date
TN2017000478A1 true TN2017000478A1 (en) 2019-04-12

Family

ID=53765408

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2017/000478A TN2017000478A1 (en) 2015-05-14 2016-05-13 Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity.

Country Status (3)

Country Link
EP (1) EP3294267A1 (en)
TN (1) TN2017000478A1 (en)
WO (1) WO2016181355A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3638276A4 (en) * 2017-06-13 2020-11-25 Mary Kay Inc. Cosmetic compositions and methods for their use in firming skin
CN107982316A (en) * 2018-01-29 2018-05-04 罗炳勇 A kind of Chinese medicine composition for being used to treat acne and freckle
CA3209718A1 (en) 2021-02-25 2022-09-01 Gary Michael PEKOE Composition for treatment of topical dermatological bacterial skin conditions
KR102715046B1 (en) * 2024-07-01 2024-10-07 이현근 Aqueous acrylic emulsion adhesive composition and manufacturing methods thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2293547A (en) * 1994-09-27 1996-04-03 Joan Louise Hibberd Compositions containing tea tree oil
CN1196490C (en) * 2002-05-22 2005-04-13 马英武 Externally-used paste for curing dermatitis
CN1262304C (en) * 2004-03-15 2006-07-05 周洪儒 Chinese medica preparation for treating dermatitis, eczema, herpes and herpes zoster
CN1301736C (en) * 2004-11-07 2007-02-28 宫世杰 Poriasis treating Chinese medicine
CN101904987A (en) * 2009-06-04 2010-12-08 赵怀谦 Formula of traditional Chinese medicine for treating stubborn dermatitis
IT1400386B1 (en) * 2010-05-27 2013-05-31 Roberto Logi KIT OF PARTS FOR THE TREATMENT AND / OR PREVENTION OF SKIN ULCERS
KR101915655B1 (en) * 2011-10-26 2018-11-06 (주)아모레퍼시픽 Cosmetic composition containing Croton Lechleri resin extract
ES2624920T3 (en) * 2012-12-19 2017-07-18 Veit Hoermann Gesellschaft Für Unternehmenskommunikation Mbh Compositions for the treatment of dermatological conditions, disorders or diseases

Also Published As

Publication number Publication date
WO2016181355A1 (en) 2016-11-17
EP3294267A1 (en) 2018-03-21

Similar Documents

Publication Publication Date Title
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
ZA201708692B (en) Antibacterial compounds
PH12017501611A1 (en) Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
EP4218743A3 (en) Compositions for use in cartilage breakdown
MX2018002543A (en) Compositions comprising urolithin compounds.
TN2015000371A1 (en) Substituted imidazopyridazines
EA201791701A1 (en) DISPENSABLE COMPOSITIONS
PH12019500243A1 (en) Warming sensation compounds
MX2023002137A (en) Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract.
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
PH12017500706B1 (en) Composition containing extract or fraction of genus justicia plant
EP4378535A3 (en) Antibiotic formulations for lower back pain
PH12017501133A1 (en) Pyrazolopyridinamines
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
WO2016142708A3 (en) Pharmaceutical composition
ZA201807446B (en) Improved drug formulations
TN2017000478A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity.
TW201613628A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
WO2017079403A3 (en) Polymeric nanoparticles
MX380429B (en) COMPOSITION FOR TREATING TISSUE INJURIES.
PH12018502181B1 (en) Formulation systems for antimicrobial glycolipids
MX2018014790A (en) Combination formulation of three antiviral compounds.
WO2018135912A3 (en) Composition comprising curcumin-captured ginsenoside and phospholipid-based lipid nanoparticle as effective ingredient for preventing or treating helicobacter pylori infection
MX2015012771A (en) Method of treating vitamin b12 deficiency.